Development of a novel cell-based assay to evaluate the malignant potential of cancer in vitro

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2541-2545

  Hirakawa, Chiasa ^a,b   Tanaka, Kunihiko ^a   Takaya, Yoshihiro ^a   Nakagawa, Shinsuke ^a,c   Kataoka, Yasufumi ^b,c   Tagawa, Yutaka ^a,c   Niwa, Masami ^a,c  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c PharmaCo Cell Co Ltd   (Japan)

Author keywords

Anoikis; Cancer; Cell based assay; Malignant potential; Matrix metalloproteinase (MMP); Metastasis

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER STAGING; CELL ADHESION; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME SYNTHESIS; EXTRAVASATION; IN VITRO STUDY; METASTASIS; MONOLAYER CULTURE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

ANIMALS; CELL LINE; CULTURE MEDIA, CONDITIONED; DOGS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASMS, EXPERIMENTAL;

EID: 69249176157     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
2. Mehlen P and Puisieux A: Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458, 2006.
3. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002. (Pubitemid 37328923)
4. Bogenrieder T and Herlyn M: Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22: 6524-6536, 2003. (Pubitemid 37372332)
5. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
6. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
7. Hendrix MJ, Seftor EA, Seftor RE and Fidler IJ: A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 38: 137-147, 1987.
8. Takaya Y, Tanaka K, Hirakawa C, Tagawa Y and Niwa M: New method for separation of subpopulations from a heterogeneous colon cancer cell line. Anticancer Res 28: 3665-3670, 2008.
9. Okada T, Li J, Kodaka M and Okuno H: Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro. Clin Exp Metastasis 76: 267-274, 1998. (Pubitemid 28201994)
10. Kao WT, Lin CY, Lee LT, Lee PPH, Hung CC, Lin YS, Chen SH, Ke FC, Hwang JJ and Lee MT: Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Res 28: 2109-2120, 2008.
11. Furuse M, Furuse K, Sasaki H and Tsukita S: Conversion of zonulae occludentes from tight to leaky strand by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153: 263-272, 2001. (Pubitemid 34280213)
12. Zak J, Schneider SW, Eue I, Ludwig T and Oberleithner H: High-resistance MDCK-C7 monolayers used for measuring invasive potency of tumour cells. Pflugers Arch 440: 179-183, 2000. (Pubitemid 30265926)
13. Ludwig T, Ossig R, Graessel S, Wilhelmi M, Oberleithner H and Schneider SW: The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion. Am J Physiol Renal Physiol 253: 319-327, 2002. (Pubitemid 34778995)
14. Fidler IJ: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35: 218-224, 1975.
15. Poste G, Doll J, Hart IR and Fidler IJ: In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 40: 1636-1644, 1980.
16. Gehlsen KR and Hendrix MJ: In vitro assay demonstrates similar invasion profiles for B16F1 and B16F10 murine melanoma cells. Cancer lett 30: 207-212, 1986.
17. Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC and Marbry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562-4569, 1976.
18. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsoskas M, Stamp GW and Stetler-Stevenson WG: Validation of a model of colon cancer progression. J Pathol 792: 446-454, 2000.
19. Dawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK and Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776, 2005.
20. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ and Matrisian LM: Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54: 4805-4812, 1994. (Pubitemid 24276516)
21. Cho CY, Wang JH, Chang HC, Chang CK and Hung WC: Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. J Cell Physiol 213: 65-69, 2007.
22. Zhu XL, Liang L and Ding YQ: Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. Int J Colorectal Dis 23: 1041-1047, 2008.
23. Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M and Esumi H: ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol 164: 987-995, 2004. (Pubitemid 38235480)
24. Che ZM, Jung TH, Choi JH, Yoon DJ, Jeong HJ, Lee EJ and Kim J: Collagen-based co-culture for invasive study on cancer cells-fibroblasts interaction. Biochem Biophys Res Commun 346: 268-275, 2006.